Benign prostatic hyperplasia (BPH) is a benign neoplasm that grows in the prostate structure (in the glandular epithelium or stromal component). The disease refers to the age-related factors. So, at the age of 40 years, it is diagnosed in 10-15% of men, while at the age of 75-80 years – in 80%. In this case, the symptoms of hyperplasia are already observed in most men 50 years and older, which is not necessarily caused by this pathology. Micturition disorders other than BPH may be due to prostate cancer, impaired detrusor activity, detrusor instability, and other bladder dysfunctions.
Symptoms of BPH occur around the main manifestation of it – violations of the urethra. Symptoms of diseases that can complicate hyperplasia are acute symptoms: acute urination, hematuria, bladder stones, pyelonephritis, cystitis, urethritis, prostatitis, orchiepididymitis, chronic renal failure.
Treatment of benign prostatic hyperplasia is represented by several strategies, which are determined by the degree of disturbance of urine outflow from the bladder, the size of the prostate, the severity of the irriative and obstructive symptoms.